A February, 2017 allergy immunotherapy research study published in JAMA recommends that patients continue their subcutaneous (allergy shots) or sublingual (allergy drops) allergy treatment for at least 3 years for long term effectiveness.
Sources: Shortened dose of immunotherapy ineffective in allergic rhinitis, All-American Allergy Alternatives, LLC